TY - CHAP M1 - Book, Section TI - Occlusive Disease: Femoral & Popliteal Arteries A1 - Gasper, Warren J. A1 - Iannuzzi, James C. A1 - Johnson, Meshell D. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. PY - 2023 T2 - Current Medical Diagnosis & Treatment 2023 AB - Key Clinical Updates in Occlusive Disease: Femoral & Popliteal ArteriesDual treatment with rivaroxaban 2.5 mg orally twice daily and aspirin 81 mg orally daily has been shown to reduce limb-related events, major amputation, and cardiovascular events.Bauersachs RM et al. J Am Coll Cardiol. [PMID: 34010631] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193148830 ER -